← The record

Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids; Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty Acids

Recommended · restricted MetabolicRestrictedNot applicable line

Eligible patients with cow's milk allergy, multiple food intolerance and other medical conditions where an amino acid-based formula is recommended.

1
Submissions
2020–20
On the record
ICER range
Not modelled
Cost basis

Access path

1 submission · public record
  1. Mar 2020
    Recommended · restricted
  2. PBS listing · Restricted
RecommendedDeferredNot recommended

From the public summary

Verbatim · PSD text · may span indications
PBAC outcome
6.1 The PBAC recommended continuing the Restricted Benefit listing of amino acid formulas Neocate® LCP and Neocate® Syneo™, for eligible patients with cow’s milk allergy, multiple food intolerance and other medical conditions where an amino acid- based formula is recommended, following its reformulation due to changes in European compositional standards.PSD · Mar 2020
6.2 The PBAC noted the NPWP supported the proposed listing of Neocate® LCP and Neocate® Syneo™ on the PBS, and noted the Pre-PBAC Response statement that dose recommendations were based on international standards.PSD · Mar 2020

Cost-effectiveness

Not applicable — this is a minor formulation change submission with no economic evaluation required.

Decision context

PopulationEligible patients with cow's milk allergy, multiple food intolerance and other medical conditions where an amino acid-based formula is recommended.

Submission history

1 entries
DecidedOutcomeComparatorICEREvidence
Mar 2020 Recommended · restricted Cost-minimisation

Similar precedents

By decision profile

Regulatory · TGA

Label narrower than PBS population — PBAC restricted subsidy to specific medical conditions (cow's milk allergy, multiple food intolerance) while TGA label covers infants requiring amino acid-based formula generally.